Moore Capital Management, LP Revance Therapeutics, Inc. Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.65 - $9.31 $465,000 - $931,000
100,000 Added 66.67%
250,000 $1.23 Million
Q4 2023

Feb 14, 2024
SELL
$5.81 - $11.2 $58,099 - $112,000
-10,000 Reduced 6.25%
150,000 $1.32 Million
Q3 2023

Nov 14, 2023
BUY
$11.47 - $25.07 $1.2 Million - $2.63 Million
105,000 Added 190.91%
160,000 $1.84 Million
Q2 2023

Aug 14, 2023
BUY
$24.7 - $37.61 $1.36 Million - $2.07 Million
55,000 New
55,000 $1.39 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email